Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.

@article{Waksman2017BioresorbableSV,
  title={Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.},
  author={Ron Waksman},
  journal={The New England journal of medicine},
  year={2017},
  volume={377 18},
  pages={1791-1792}
}
BACKGROUND Bioresorbable vascular scaffolds were developed to overcome the shortcomings of drug-eluting stents in percutaneous coronary intervention (PCI). We performed an investigator-initiated, randomized trial to compare an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in the context of routine clinical practice. METHODS We randomly assigned 1845 patients undergoing PCI to receive either a bioresorbable vascular scaffold (924 patients) or a metallic… CONTINUE READING